BioSpace News Archive

Policy

Endo Lifts Temporary Stay of FDA Litigation Following the Launch of a Bulk-Compounded Vasopressin Product by a Section 503B Outsourcing Facility

The litigation also seeks the immediate removal of vasopressin from FDA’s Category 1 nominations list to assure that outsourcing facilities do not engage in bulk compounding of vasopressin-containing drug products under Section 503B.

August 15, 2018
·
5 min read
Business

Constellation Brands to Invest $5 Billion CAD [$4 Billion USD] in Canopy Growth to Establish Transformative Global Position and Alignment

Expands Strategic Partnership to Accelerate Canopy Growth’s Global

August 15, 2018
·
11 min read
Genetown

ProQR to Present Interim Phase 1/2 Results for QR-110 in Leber’s Congenital Amaurosis 10 at the Symposium for Retinal Degeneration on Sept. 5th

Presentation at the 18th International Symposium on Retinal Degeneration (RD2018) at 8:30 am GMT on Sept. 5th

August 15, 2018
·
4 min read
Biotech Beach

International Stem Cell Corporation Announces Record Sales and Operating Results for the Three and Six-Months ended June 30, 2018

Consolidated revenue for the six months ended June 30, 2018 was $5.7 million, an increase of 50% compared to the consolidated revenue of $3.8 million for the six months ended June 30, 2017.

August 15, 2018
·
8 min read
Business

ADAPT Pharma & the Independent Pharmacy Cooperative (IPC) Announce Collaboration to Educate Member Pharmacies

More than 2,500 pharmacies across the United States will have access to a new educational video, demonstration units and patient education materials.

August 15, 2018
·
5 min read
Job Trends

Health Catalyst Named to Inc. 5000 for the Sixth Consecutive Year

Healthcare technology innovator’s growth streak outperforms 94 percent of Inc. 5000 listed companies since 1982

August 15, 2018
·
4 min read
Business

Spherix Announces Strategic Equity Investment in DatChat in Lieu of Full Company Merger

Revised Investment Terms Provides Shareholders with Cybersecurity Growth Opportunity

August 15, 2018
·
3 min read
Business

Intec Pharma Reports Second Quarter 2018 Financial Results and Corporate Update

Enrolled more than 95% of patients in pivotal Phase 3 ACCORDANCE trial and more than 85% of eligible patients entered the open label extension study

August 15, 2018
·
30 min read
Business

GeneNews Announces Q2 2018 Results and Provides Progress Update

Closed on the first tranche of the Unit private placement for C$1.2 million and the Lind convertible security for C$2 million

August 15, 2018
·
4 min read
Drug Development

Novocure and US Oncology Research Announce Collaboration on PANOVA-3 Trial for Patients with Advanced Pancreatic Cancer

US Oncology Research will open 10 clinical trial sites, enrolling patients in Novocure’s PANOVA-3 trial to test the efficacy of Tumor Treating Fields combined with nab-paclitaxel and gemcitabine in patients with unresectable locally advanced pancreatic cancer

August 15, 2018
·
6 min read